CAR T cell therapy is a personalized treatment given in a one-time infusion

When a person chooses to receive CAR T cell therapy, their treatment is made specifically for them, from their own T cells.

The CAR T cell treatment process has been proven by years of experience

CAR T cell therapy is not yet approved to treat autoimmune diseases. It is only available to people with autoimmune diseases in clinical studies.

But for other conditions, CAR T cell therapy was first given to patients in a clinical study in 2011. Since then, it has been prescribed for thousands of patients around the world.

There are 3 steps to CAR T cell therapy

CAR T cell therapy is given at a certified treatment center by an experienced healthcare team. It is a multistep process that takes several visits.

STEP 1: Before CAR T cell treatment

Blood collection

The patient’s blood is taken through a process called apheresis. The T cells are collected, and the other parts of the blood are returned to the patient’s body.

CAR T cell creation

The patient’s T cells are sent to a manufacturing facility where CARs are added. They are now CAR T cells with the power to find and destroy specific cells, which may include overactive and healthy cells.

Preparing for CAR T cell therapy

Before receiving CAR T cells, the patient receives a pre-infusion treatment to help prepare their body for treatment.

STEP 2: Treatment day

One-time CAR T cell therapy infusion

The patient’s CAR T cells are returned to their body in a one-time infusion.

STEP 3: After treatment

Monitoring

After the infusion of new CAR T cells, the patient is closely monitored for side effects by the healthcare team at the certified center. CAR T cell treatment is complete. Long-term care may be overseen by the healthcare provider who originally referred the patient for CAR T cell therapy. Throughout, the patient's care partner also helps to keep an eye on how the patient is doing.